Yatırımcı.AI

BISTTRY12:19Live

Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş.

ONCSM Ratio Analysis: P/E, P/B, EV/EBITDAOncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş.

Main MarketChemicals, Petroleum, Rubber and Plastics
95.50−2.00 (−2.05%)
Volume
TRY 69M
Day range
94.70 – 98.95
Previous close
97.50
Market cap
TRY 2.3B

Last updated: Source: Borsa Istanbul, 15-minute delayed

35 key ratios for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.Ş. (ONCSM) computed from the latest financial statements and the current price: valuation, profitability, liquidity, leverage and efficiency.

Ratio Analysis

P/E25.29
P/B4.07
EV/EBITDA7.12
Dividend yield—
Beta—
Earnings per share3.8 TL
Book value per share23.5 TL
EBITDA260.5M TL
Net profit60.5M TL
Operating profit194.6M TL
Operating profit before finance costs194.7M TL
Net working capital301.9M TL
Gross margin51.48%
Operating margin24.02%
Net margin7.47%
Return on assets10.74%
Return on equity16.90%
Current ratio2.35
Quick ratio1.93
Cash ratio—
Leverage ratio37.95
Debt to equity0.61
Debt to assets0.38
Fixed assets to equity0.67
Short-term debt share0.03
Interest coverage—
Receivables turnover1.56
Days sales outstanding234
Inventory turnover4.16
Days inventory outstanding88
Payables turnover7.48
Days payables outstanding49
Working capital turnover2.68
Equity turnover1.45
Asset turnover0.90

Frequently Asked Questions

ONCSM has a P/E ratio of 25.29, a P/B ratio of 4.07 and an EV/EBITDA of 7.12.

Price-based ratios (P/E, P/B, EV/EBITDA, dividend yield) refresh daily; balance-sheet ratios refresh after the company publishes its KAP financial report.